The CRC Blueprint

My scientific approach to my own cancer – shared with you.

Phase 2

A Study of YL202 in Patients With Advanced Solid Tumors

Phase 2 · 100 people · 1 site in China · Recruiting now

August 11, 2026
Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Phase 2 · 210 people · 1 site in China · Recruiting now

August 11, 2026
Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

Phase 2 · 40 people · 20 sites in 10 countries · Recruiting now

August 11, 2026
A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

Phase 2 · 78 people · 1 site in United States · Recruiting now

August 11, 2026
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Phase 2 · randomised · 97 people · 2 sites in United States · Recruiting now

August 11, 2026
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Phase 2 · 126 people · 5 sites in United States · Recruiting now

August 11, 2026
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC

Phase 2 · 40 people · 1 site in United States · Recruiting now

August 11, 2026
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

Phase 2 · 50 people · 9 sites in United States · Recruiting now

August 11, 2026
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Phase 2 · 70 people · 1 site in United States · Recruiting now

August 11, 2026
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Phase 2 · 50 people · 1 site in United States · Recruiting now

August 11, 2026